Contract award · 8 Sep 2025

Romiplostim (Nplate®)

The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded “Romiplostim (Nplate®)” to Amgen Ltd for £5.61m.

No competitionMedical equipment & pharmaceuticalsScotland

Awarded without open competition

Awarded without open competition. The buyer went directly to one or a few suppliers instead of advertising the contract. Procurement rules allow this only in specific cases, such as extreme urgency, when only one supplier can do the work, or for call-offs from an existing framework.

What “without competition” means

Key facts

Supplier
Amgen Ltd
Value
£5,610,178
Procedure
Negotiated without publication of a contract notice
Sector
Medical equipment & pharmaceuticals · Pharmaceutical products (CPV 33600000)
Region
Scotland
Timeline
  1. Contract date8 Sep 2025
  2. Published10 Sep 2025Published 2 days after the contract date

Description

Supply of Romiplostim (NPlate®) to NHS Scotland.

About the supplier

  • Amgen Ltd: every public contract they have won.

Other awards in the same procurement

Call-offs and awards published under the same process (for example a framework or dynamic purchasing system).

Date Contract Supplier Value
29 Sep 2025
Romiplostim (Nplate®) No competition
Amgen Ltd £5.61m

More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)

All contracts

More won by Amgen Ltd

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview